Kezar Life Sciences, Inc.KZR
Market cap
$45.73M
P/E ratio
| 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Depreciation & amortization | 1 | 1 | 2 | 2 | 1 | 1 | 1 |
| Stock-based compensation | 2 | 4 | 5 | 8 | 14 | 18 | 13 |
| Cash from operations | -21 | -30 | -37 | -42 | -59 | -82 | -74 |
| Capital expenditures | -1 | -1 | -0 | -0 | -2 | -2 | -0 |
| Cash from investing | -84 | 20 | -56 | -28 | -91 | 76 | 80 |
| Proceeds from issuance of term debt, net | - | - | - | 10 | - | - | - |
| Cash from financing | 78 | 0 | 100 | 113 | 128 | 1 | 0 |
| Free cash flow | |||||||
| FCF margin (%) | - | - | - | - | - | - |